Cargando…
Comparison of Severity of COVID-19 Infection among Patients Using RAAS Inhibitors and Non-RAAS Inhibitors
AIMS AND OBJECTIVES: The aim of the article was to study the safety profile of renin-angiotensin-aldosterone system (RAAS) inhibitor in COVID-19-affected Indian patients. INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for COVID-19 infection. There has been...
Autores principales: | Reddy, Paidi Ramakrishna, Samavedam, Srinivas, Aluru, Narmada, Boggu, Rajyalakshmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138629/ https://www.ncbi.nlm.nih.gov/pubmed/34045800 http://dx.doi.org/10.5005/jp-journals-10071-23774 |
Ejemplares similares
-
Metabolic Resuscitation Using Hydrocortisone, Ascorbic Acid, and Thiamine: Do Individual Components Influence Reversal of Shock Independently?
por: Reddy, Paidi Ramakrishna, et al.
Publicado: (2020) -
Prognostic Value of “Cycle Threshold” in Confirmed COVID-19 Patients
por: Rajyalakshmi, B, et al.
Publicado: (2021) -
RAAS INHIBITORS ARE CARDIOPROTECTIVE IN PATIENTS WITH COVID-19
por: Holmes, Adam R., et al.
Publicado: (2021) -
A Shot in the Dark! RAAS Inhibitors Cause Severe COVID-19 Infection
por: Krishna, Bhuvana
Publicado: (2021) -
RAAS inhibitors do not increase the risk of COVID-19
por: Fernández-Ruiz, Irene
Publicado: (2020)